Drilldown: Medicines
Medicines > fda max:
4 mg/d (schizophrenia); 3 mg/d (AD agitation); 3 mg/d (MDD adjunct) 
& onset :
Postprandial glucose effect within days; HbA1c by 12 weeks or
Triglyceride lowering at 2-4 weeks; max at 8 weeks
& onset :
Postprandial glucose effect within days; HbA1c by 12 weeks or
Triglyceride lowering at 2-4 weeks; max at 8 weeks Use the filters below to narrow your results.
generic:
(There are no values for this filter)
brand:
(There are no values for this filter)
classes:
(There are no values for this filter)
mechanism:
(There are no values for this filter)
uses:
(There are no values for this filter)
starting dose:
(There are no values for this filter)
preparations:
(There are no values for this filter)
fda max: (Click arrow to add another value)
routes:
(There are no values for this filter)
onset: (Click arrow to add another value)
duration:
(There are no values for this filter)
halflife:
(There are no values for this filter)
bioavailability:
(There are no values for this filter)
pregnancy:
(There are no values for this filter)
legal:
(There are no values for this filter)
There are no results for this report.